Heart failure drug under the microscope: new study tracks Real-World safety
NCT ID NCT05666518
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 23 times
Summary
This study follows 1400 Japanese people with chronic heart failure who are prescribed vericiguat by their doctors. Researchers will track side effects and heart-related deaths over two years to see how safe the drug is in real-world use. Participants continue their normal treatment, and no new drugs are given.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Japanese registries
RECRUITINGMultiple Locations, Many Locations, Japan
Conditions
Explore the condition pages connected to this study.